Header image

Session 3B: Aligning clinical supply and cell therapy for scalable impact

Tracks
Track 3
Wednesday, October 22, 2025
4:05 PM - 4:50 PM
Momentum Room

Details

Cell therapies are redefining the future of medicine, offering potentially curative treatments for cancer, autoimmune disorders, and genetic diseases. But their promise comes with unprecedented operational challenges—from complex manufacturing timelines to real-time patient coordination and ultra-cold chain logistics. This panel brings together cross-functional leaders to discuss how alignment is critical for successful clinical trial execution. By combining scientific vision with supply innovation, we will explore strategies to overcome the key challenges in cell therapy trial, particularly in international settings involving multi-site coordination, cross-border transport, and varying regulatory requirements. Special attention will be given to the management of cell therapy products across global locations, including strategies for harmonising site processes and maintaining traceability. Additionally, the panel will highlight best practices for conducting in-use compatibility studies and managing ancillary materials—key, but often overlooked, aspects of cell therapy development.


Speaker

Agenda Item Image
Miss Amel Hadri
Chief Executive Officer & Founder
Inits Group

Chair

Agenda Item Image
Dr. Kilian Kelly
Chief Executive Officer and Managing Director
Cynata

Panellist

Agenda Item Image
Mr Brent McPherson
Director, Business Development Australian and New Zealand
WORLD COURIER (AUST) PTY LTD

Panellist

Agenda Item Image
Miss Gwendoline Peter
Clinical Supply Expert
Inits

Panellist

Agenda Item Image
A/Prof. Tina Soulis
Founder and Director
Alithia Life Sciences Pty Ltd

Panellist

Agenda Item Image
Mr Silvio Tiziani
Chief Executive Officer
CCRM Australia

Panellist

loading